1Aonuma S, Kohama Y,Akai K, Komiyama Y, et al . Studies on heart. XIX. Isolation of an atrial peptide that improves the rhythmicitg of cultured myocardial cell clusters. Chem Pharm Bull(Tokyo)1980 :28:3332-3339.
2Kohama Y, Iwabucbi K. Shibahara T . et at. Respoose of immunoreactive antiarrhythmic peptide (IR-AAP) level associated with experimental arrhythmia in rats. J Pharmacobiodyn, 1985,9:806-810.
4Argentieri T,Cantor E ,Wlggins JR. Antiarrhythmic peptide has no direct cardiac actions. Experientia,1989,45:737-738.
5Muller A,Schaefer T,Linke W,et al. Actions of the antiarrhythmic peptide AAP10 on intercellular coupling. Naunyn Schmiede bergs Arch Pharmacol, 1997,356:76 -82.
6Dhein S, Manicone N . Muller A, et ah A new synthetic antiarrhythmic peptide reduces disperston of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study. Naunyn Schmiedebergs Arch Pharmacol, 1994,350 : 174-184.
7Kohama Y,Iwabuchi K,Okabe M,et al. Potent platelet antiaggregant action of an antiarrhythmic peptide (AAP). J Pharmacobiodyn ,1986,9:182-188.
8Kohama Y, Kawahara Y, Okabe M, et al. Determination of immunoreactive antiarrhythmic peptide (AAP)in rats. J Pharmacobiodyn 1985,8 : 1024-1031.
